Abstract
Objective Our work aimed to study the epidemiological and clinical aspects of Tetralogy of Fallot (TF) in the cardiology unit of the Saint-Damien Nos Petits Frères et Sœurs hospital in Haiti.
Methodology This is a retrospective study of patients aged 0 to 18 years with Tetralogy of Fallot confirmed by echocardiography. Data were entered using an elaborated form and analyzed with Epi Info software version 7.2.2.16 and Microsoft Excel 2013.
Results From January 2019 to December 2021, we identified 102 patients aged 0 to 18 years with TF. A male predominance was noted with a sex ratio M/F of 1.55. The average age of discovery of our cohort was 3 years and 7 months [0-16 years; standard deviation: 9.9]. The clinical signs were dominated by a systolic murmur (91.18%) followed by cyanosis (39.22%) and dyspnea (33.33%). On echocardiography, the regular form (76.47%) associated with the severe stenosis (83.33%) was remarkable. 20.59% of patients were able to benefit from surgery and the mortality rate was 14.94%. Patients were presenting at an advanced stage where they mostly needed surgical treatment to survive.
Conclusion This study shows that the prevalence of TF is also high in developing countries. The heart murmur at the pulmonary focus and the cyanosis were more present on physical examination. Patients were presenting at an advanced stage where they mostly needed surgical treatment to survive. Preventive measures are needed to reduce the mortality rate.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Faculty of Medicine and Health Sciences of the University of Notre Dame D'Haiti gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
